News tagged with antigens
Novel brain tumor vaccine acts like bloodhound to locate cancer cells
A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate.
Jan 05, 2012 |
not rated yet |
0
|
Researchers identify lipid profile characteristic of newly diagnosed type 1 diabetes
(PhysOrg.com) -- A journal article showcasing results of lipidomics analyses for identifying novel biomarkers of diabetes conducted at Pacific Northwest National Laboratory was selected as "Editor's Choice" ...
Dec 30, 2011 |
4 / 5 (2) |
0
|
Prostate cancer test still holds value: Urologist addresses common myths about the disease
(Medical Xpress) -- Earlier this year, the U.S. Preventive Services Task Force announced recommendations that surprised the medical community: Healthy men should no longer have the prostate specific antigen (PSA) test to ...
Dec 23, 2011 |
3.5 / 5 (2) |
0
Biopsy referral after PSA screening stays consistent over time
After the US Prostate Cancer Prevention Trial found cancer in many men with low levels of prostate specific antigen (PSA), many debated which PSA level should lead to a biopsy recommendation. The US Preventive Screening Task ...
Dec 13, 2011 |
not rated yet |
0
Research describes advantages of new vaccine adjuvant
New research from the laboratory of Dr. Elizabeth Leadbetter at the Trudeau Institute may lead to a whole new class of vaccines. Dr. Leadbetter's lab has discovered new properties of a potential vaccine adjuvant that suggest ...
Dec 12, 2011 |
5 / 5 (1) |
0
Promising results in mice on needle-free candidate universal vaccine against various flu viruses
Scientists from the International Vaccine Institute (IVI) have discovered that an antigen common to most influenza viruses, and commonly referred to as matrix protein 2 (M2), when administered under the tongue could protect ...
Dec 08, 2011 |
5 / 5 (1) |
0
Heart health risk of prostate cancer treatment being ignored, warn specialists
Heart disease and stroke are emerging complications of treating prostate cancer with drugs to suppress testosterone production, yet standard management of the disease is ignoring this risk, warn specialists in a viewpoint ...
Medicine & Health / Cardiology
Dec 07, 2011 |
4 / 5 (1) |
0
Study: men less willing to be screened for cancer
Although men have higher cancer mortality rates than women, they are less willing to be screened for cancer, according to a study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Sanoa Consulting ...
Nov 22, 2011 |
not rated yet |
1
Catch the fever: It'll help you fight off infection
With cold and flu season almost here, the next time you're sick, think twice before taking something for your fever. That's because scientists have found more evidence that elevated body temperature helps certain types of ...
Nov 01, 2011 |
5 / 5 (3) |
0
|
A better target for B-cell lymphomas: From a library of MAG antagonists to nanomolar CD22 ligands
Patients suffering from B-cell lymphomas can be treated with antibodies directed against the B-lymphocyte antigen CD20.
Oct 25, 2011 |
not rated yet |
0
|
A safer vaccination for Alzheimer's disease?
The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of ...
Oct 11, 2011 |
not rated yet |
0
Transplant survival could be improved by altering present criteria for matching donors, recipients
Selecting better matched recipients and donors than is currently required for umbilical-cord blood transplantation could substantially reduce transplant-related deaths. The findings, published Online First in the Lancet On ...
Oct 06, 2011 |
not rated yet |
0
More aggressive treatment not necessary for men with a family history of prostate cancer
Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, ...
Oct 05, 2011 |
not rated yet |
0
Shorter radiation course for prostate cancer is effective in long-term follow-up
A shorter course of radiation treatment that delivers higher doses of radiation per day in fewer days (hypofractionation) is as effective in decreasing intermediate to high-risk prostate cancer from returning as conventional ...
Sep 26, 2011 |
not rated yet |
0
New system finds prostate cancer spread earlier than conventional imaging
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a way to image the spread of a particularly dangerous form of prostate cancer earlier than conventional imaging in use today, which may allow oncologists ...
Sep 22, 2011 |
5 / 5 (1) |
0
|
Antigen
An antigen is a foreign molecule that, when introduced into the body, triggers the production of an antibody by the immune system. The immune system will then kill or neutralize the antigen that is recognized as a foreign and potentially harmful invader. These invaders can be molecules such as pollen or cells such as bacteria. The term originally came from antibody generator and was a molecule that binds specifically to an antibody, but the term now also refers to any molecule or molecular fragment that can be bound by a major histocompatibility complex (MHC) and presented to a T-cell receptor. "Self" antigens are usually tolerated by the immune system; whereas "Non-self" antigens are identified as invaders and attacked by the immune system. self antigens.
An immunogen is a specific type of antigen. An immunogen is a substance that is able to provoke an adaptive immune response if injected on its own. An immunogen is able to induce an immune response, whereas an antigen is able to combine with the products of an immune response once they are made. The overlapping concepts of immunogenicity and antigenicity are, therefore, subtly different. According to a current textbook:
Immunogenicity is the ability to induce a humoral and/or cell-mediated immune response
Antigenicity is the ability to combine specifically with the final products of the immune response (i.e. secreted antibodies and/or surface receptors on T-cells). Although all molecules that have the property of immunogenicity also have the property of antigenicity, the reverse is not true."
At the molecular level, an antigen is characterized by its ability to be "bound" at the antigen-binding site of an antibody. Note also that antibodies tend to discriminate between the specific molecular structures presented on the surface of the antigen (as illustrated in the Figure). Antigens are usually proteins or polysaccharides. This includes parts (coats, capsules, cell walls, flagella, fimbrae, and toxins) of bacteria, viruses, and other microorganisms. Lipids and nucleic acids are antigenic only when combined with proteins and polysaccharides. Non-microbial exogenous (non-self) antigens can include pollen, egg white, and proteins from transplanted tissues and organs or on the surface of transfused blood cells. Vaccines are examples of immunogenic antigens intentionally administered to induce acquired immunity in the recipient.
Cells present their immunogenic-antigens to the immune system via a histocompatibility molecule. Depending on the antigen presented and the type of the histocompatibility molecule, several types of immune cells can become activated.
For more information about Antigen, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.